COVID-19 Variant Supplement – Peptide macrocycle decoys against COVID‑19 viral spike protein Perrin, David M | University of British Columbia | Operating Grant | $50,000 CIHR British Columbia 2021 Read More
Repurposing an FDA-approved anti-gout drug for the treatment of COVID-19 Luo, Honglin | University of British Columbia | Project Grant | $562,275 CIHR British Columbia 2021 Read More
COVID-19 Variant Supplement – Contribution of genetic variation of ACE2, the receptor for SARS-CoV-2, to COVID‑19 disease expression and development of therapeutics Haas, Kurt | University of British Columbia | Operating Grant | $50,000 CIHR British Columbia 2021 Read More
